• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部癌治疗后迟发性放射性吞咽困难:一项范围综述

Late radiation-associated dysphagia following treatment for head and neck cancer: a scoping review.

作者信息

Sellstrom Diane, Patterson Joanne M, Finch Tracy, O'Hara James, Haighton Catherine

机构信息

The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle-Upon-Tyne, UK.

Dept. Speech, Voice and Swallowing, Freeman Hospital, Freeman Road, Newcastle-Upon-Tyne, UK.

出版信息

Support Care Cancer. 2025 May 22;33(6):493. doi: 10.1007/s00520-025-09540-4.

DOI:10.1007/s00520-025-09540-4
PMID:40405012
Abstract

PURPOSE

To provide an overview of existing literature reporting swallowing outcomes beyond two years post- head and neck cancer treatment. Objectives were to establish prevalence of late radiation-associated dysphagia (-RAD); identify risk factors of developing late-RAD and synthesise the dysphagia findings reported.

METHODS

The PRISMA-ScR checklist for conducting scoping reviews was adopted. Searches of PubMed, EMBASE, Scopus, CINAHL, Web of Science, OpenGrey, Google Scholar and Google Advanced were completed by December 2022. Eligibility criteria included studies written in English from 1996 reporting swallowing outcomes from 2 years or more post-treatment. Data was extracted from included studies, tabulated, synthesised and reported as categories.

RESULTS

Screening 7671 studies resulted in 39 studies included in the review. There was wide variation in dysphagia outcome measures used and timing of collection across studies. Prevalence could not be established. All studies reported a degree of impairment in at least one measure in a proportion of patients. Numerous risk factors were identified (including tumour site, and T-classification, age, radiotherapy dose), but there were conflicting findings and meaningful synthesis was challenging. Characteristics of late-RAD included high aspiration rates; reduced efficiency of swallowing and lower cranial neuropathy.

CONCLUSION

Significant gaps exist in the evidence base regarding late-RAD such as who is affected, why and what the trajectory of decline will be. Swallowing safety is often compromised. A consensus on the definition of late-RAD is needed along with increased uniformity in collection of outcome measures, in order to improve understanding and guide future research and service delivery models.

摘要

目的

概述现有关于头颈癌治疗两年后吞咽结果的文献。目标是确定晚期放射性吞咽困难(-RAD)的患病率;识别发生晚期RAD的风险因素,并综合所报告的吞咽困难研究结果。

方法

采用PRISMA-ScR清单进行范围综述。截至2022年12月,完成了对PubMed、EMBASE、Scopus、CINAHL、Web of Science、OpenGrey、谷歌学术和谷歌高级搜索的检索。纳入标准包括1996年以来用英文撰写的报告治疗后两年或更长时间吞咽结果的研究。从纳入研究中提取数据,制成表格,进行综合并按类别报告。

结果

筛选7671项研究后,有39项研究纳入综述。各研究中使用的吞咽困难结果测量方法和收集时间差异很大。无法确定患病率。所有研究均报告了一定比例的患者至少在一项测量中有某种程度的损伤。确定了许多风险因素(包括肿瘤部位、T分期、年龄、放疗剂量),但研究结果相互矛盾,进行有意义的综合具有挑战性。晚期RAD的特征包括高误吸率、吞咽效率降低和下颅神经病变。

结论

关于晚期RAD的证据基础存在重大差距,例如哪些人会受到影响、原因以及病情下降的轨迹。吞咽安全常常受到损害。需要就晚期RAD的定义达成共识,并提高结果测量收集的一致性,以增进理解并指导未来的研究和服务提供模式。

相似文献

1
Late radiation-associated dysphagia following treatment for head and neck cancer: a scoping review.头颈部癌治疗后迟发性放射性吞咽困难:一项范围综述
Support Care Cancer. 2025 May 22;33(6):493. doi: 10.1007/s00520-025-09540-4.
2
Assessment and management of late radiation-associated dysphagia after treatment for head and neck cancer: A scoping review and survey of UK speech and language therapists.头颈部癌治疗后迟发性放射性吞咽困难的评估与管理:一项针对英国言语和语言治疗师的范围综述及调查
Int J Lang Commun Disord. 2025 Jan-Feb;60(1):e13154. doi: 10.1111/1460-6984.13154.
3
Fiberoptic Endoscopic Evaluation of Swallowing (FEES) in Head and Neck Cancer Patients with Late Radiation-Associated Dysphagia: Swallowing Safety, Efficacy, and Dysphagia Phenotype.头颈部癌症伴晚期放射性吞咽困难患者的纤维内镜吞咽功能评估(FEES):吞咽安全性、有效性及吞咽困难表型
Curr Oncol. 2025 Apr 16;32(4):233. doi: 10.3390/curroncol32040233.
4
Therapeutic exercises for affecting post-treatment swallowing in people treated for advanced-stage head and neck cancers.针对晚期头颈癌患者治疗后吞咽功能的治疗性锻炼
Cochrane Database Syst Rev. 2016 Aug 26;2016(8):CD011112. doi: 10.1002/14651858.CD011112.pub2.
5
Manual Therapy for Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors: The MANTLE Nonrandomized Clinical Trial.头颈部癌症幸存者中与纤维化相关的迟发性吞咽困难的手法治疗:MANTLE非随机临床试验
JAMA Otolaryngol Head Neck Surg. 2025 Apr 1;151(4):319-327. doi: 10.1001/jamaoto.2024.5157.
6
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
7
Factors associated with acute and late dysphagia in the DAHANCA 6 & 7 randomized trial with accelerated radiotherapy for head and neck cancer.头颈部癌加速放疗的 DAHANCA 6 和 7 随机试验中与急性和迟发性吞咽困难相关的因素。
Acta Oncol. 2013 Oct;52(7):1535-42. doi: 10.3109/0284186X.2013.824609.
8
Late dysphagia after radiotherapy-based treatment of head and neck cancer.头颈部癌症放疗后晚期吞咽困难。
Cancer. 2012 Dec 1;118(23):5793-9. doi: 10.1002/cncr.27631. Epub 2012 May 17.
9
Persistent dysphagia after head and neck radiotherapy: a common and under-reported complication with significant effect on non-cancer-related mortality.头颈部放疗后持续性吞咽困难:一种常见但报告不足的并发症,对非癌症相关死亡率有重大影响。
Clin Oncol (R Coll Radiol). 2014 Nov;26(11):697-703. doi: 10.1016/j.clon.2014.08.009. Epub 2014 Sep 16.
10
Nutrition impact symptoms and associated outcomes in post-chemoradiotherapy head and neck cancer survivors: a systematic review.放化疗后头颈部癌症幸存者的营养影响症状及相关结局:系统评价。
J Cancer Surviv. 2018 Aug;12(4):479-494. doi: 10.1007/s11764-018-0687-7. Epub 2018 Mar 20.

本文引用的文献

1
Assessment and management of late radiation-associated dysphagia after treatment for head and neck cancer: A scoping review and survey of UK speech and language therapists.头颈部癌治疗后迟发性放射性吞咽困难的评估与管理:一项针对英国言语和语言治疗师的范围综述及调查
Int J Lang Commun Disord. 2025 Jan-Feb;60(1):e13154. doi: 10.1111/1460-6984.13154.
2
Electromyography findings in radiation-induced unilateral tongue immobility.放射性单侧舌运动障碍的肌电图表现。
Head Neck. 2024 Jun;46(6):1304-1309. doi: 10.1002/hed.27692. Epub 2024 Feb 14.
3
Longitudinal functional outcomes and late effects of radiation following treatment of nasopharyngeal carcinoma: secondary analysis of a prospective cohort study.
鼻咽癌治疗后纵向功能结局和晚期放射效应:前瞻性队列研究的二次分析。
J Otolaryngol Head Neck Surg. 2022 Nov 8;51(1):41. doi: 10.1186/s40463-022-00593-7.
4
Quality of life in head and neck cancer patients at 5 years after free flap reconstruction: a significant decline during the follow-up.头颈部癌症患者游离皮瓣重建术后 5 年的生活质量:随访期间显著下降。
Eur Arch Otorhinolaryngol. 2022 Aug;279(8):4069-4075. doi: 10.1007/s00405-021-07242-1. Epub 2022 Jan 5.
5
An Updated Review on Head and Neck Cancer Treatment with Radiation Therapy.头颈部癌放射治疗的最新综述
Cancers (Basel). 2021 Sep 30;13(19):4912. doi: 10.3390/cancers13194912.
6
Report on Late Toxicity in Head-and-Neck Tumor Patients with Long Term Survival after Radiochemotherapy.头颈部肿瘤患者放化疗后长期生存的晚期毒性报告
Cancers (Basel). 2021 Aug 26;13(17):4292. doi: 10.3390/cancers13174292.
7
Radiation-induced swallowing dysfunction in patients with head and neck cancer: A literature review.头颈部癌患者的放射性吞咽功能障碍:文献综述。
J Formos Med Assoc. 2022 Jan;121(1 Pt 1):3-13. doi: 10.1016/j.jfma.2021.06.020. Epub 2021 Jul 8.
8
Identification and management of late dysfunction in survivors of head and neck cancer: Implementation and outcomes of an interdisciplinary quality of life (IQOL) clinic.头颈部癌症幸存者晚期功能障碍的识别和管理:跨学科生活质量(IQOL)临床实践的实施和结果。
Head Neck. 2021 Jul;43(7):2124-2135. doi: 10.1002/hed.26681. Epub 2021 Mar 21.
9
European white paper: oropharyngeal dysphagia in head and neck cancer.欧洲白皮书:头颈部癌症患者的口咽吞咽困难。
Eur Arch Otorhinolaryngol. 2021 Feb;278(2):577-616. doi: 10.1007/s00405-020-06507-5. Epub 2020 Dec 19.
10
Late and Long-Term Treatment-Related Effects and Survivorship for Head and Neck Cancer Patients.头颈部癌症患者的晚期及长期治疗相关影响与生存情况
Curr Treat Options Oncol. 2020 Oct 3;21(12):92. doi: 10.1007/s11864-020-00797-x.